Penn Medicine Abramson Cancer Center

 

Insights from 2024 WCLC
M

WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Therapy for NSCLC - Rational Targeted Combinations

By Insights from 2024 WCLC FEATURING Melina Marmarelis
By Insights from 2024 WCLC FEATURING Melina Marmarelis
113 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Videos
07:04

New

Mesothelioma Trial Updates: CheckMate 743, IND 227, BEAT-Meso, MARS2

Penn Medicine Abramson Cancer Center

M. Marmarelis

41 views
11:50

New

ASCO® GU 2025 Insights: Initial Biopsy Results Screening for Inherit…

Insights from 2025 ASCO® GU Annual Meeting

D. Lee

25 views
04:26

ASCO® GI 2025 Insights: Geriatric and QoL Assessments on Gem/Nab-Pac…

Insights from 2025 ASCO® GI Annual Meeting

E. Dotan

63 views
08:24

The Promise of Immunotherapies in T-Cell Lymphomas

Penn Medicine Abramson Cancer Center

C. Thomas

47 views
09:00

Pirtobrutinib Updates in CLL - Considerations for Practice

Penn Medicine Abramson Cancer Center

J. Svoboda

128 views
15:07

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

336 views
08:02

WCLC 2024 Summary: Intensifying Suboptimal Response to Targeted Ther…

Insights from 2024 WCLC

M. Marmarelis

113 views
07:48

WCLC 2024 Insights: Long-Term Follow Up on Pembro + Itacitinib in PD…

Insights from 2024 WCLC

M. Marmarelis

22 views
26:09

A Multidisciplinary Team Approach to TTP

Penn Medicine Abramson Cancer Center

D. Siegel

179 views
09:30

ESMO 2023 Summary: "The CLEVER Trial - Targeting Disseminated Dorman…

Insights from 2023 ESMO Annual Meeting

A. DeMichele

90 views
08:21

SOHO 2023 Results from the QuANTUM-First Trial: Impact of allo-HCT i…

SOHO 2023 Eleventh Annual Meeting

A. Perl

50 views
09:47

2023 ASCO® Direct Philadelphia: Phase 3 OVHIPEC-1 Trial Final Surviv…

Total Health

A. Smith

178 views
09:57

2023 ASCO® Direct Philadelphia: Phase 3 SHAPE Trial - Radical vs. Si…

Total Health

A. Smith

107 views
10:29

2023 ASCO® Direct Philadelphia: RUBY Trial Review - Dostarlimab + Ch…

Total Health

A. Smith

82 views
27:15

Metastatic NSCLC Updates - 2023 ASCO® Direct Philadelphia

Total Health

S. Kazmi

141 views
09:27

2023 ASCO® Direct Philadelphia: TRANSCEND CLL 004 Study - CLL/SLL Up…

Total Health

J. Svoboda

17 views
05:12

2023 ASCO® Direct Philadelphia: Phase 3 ZUMA-7 Study - R/R DLBCL Upd…

Total Health

J. Svoboda

55 views
15:24

2023 ASCO® Direct Philadelphia: Hodgkin Lymphoma Updates

Total Health

J. Svoboda

171 views
18:13

Surgical Management of CRC Liver Metastases - 2023 ASCO® Direct Phil…

Total Health

R. Roses

104 views
20:46

Perioperative Therapy for Early Stage NSCLC - Best of Lung 2023

Total Health

S. Kazmi

201 views
17:32

ADAURA Trial Update: Osimertinib in Resected EGFRm NSCLC - Best of L…

Total Health

S. Kazmi

131 views
26:00

Neoadjuvant Therapy for Resectable Melanoma

International Congress on Cancer Metastasis

G. Karakousis

183 views
05:46

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

306 views
05:27

Treatment Strategies in ALL: Journey to MRD Negativity

Penn Medicine Abramson Cancer Center

C. Lai

77 views
16:19

ASCO GI 2023 Exploring Immunotherapy Combinations for DDR-Deficient …

ASCO GI 2023 Conference Coverage

K. Reiss Binder

136 views
09:17

The Role of Adjuvant Targeted Therapy in rNSCLC

Penn Medicine Abramson Cancer Center

M. Marmarelis

452 views
18:34

2022 Delivery of Care for Cancer Patients During the COVID-19 Pandem…

Penn Medicine Abramson Cancer Center

L. Schuchter

8 views
15:32

Update on Treatment of COVID-19 Infection for Cancer and Other Immun…

Penn Medicine Abramson Cancer Center

K. Murphy

12 views
15:15

Update on Treatment and Prevention of COVID-19 in Cancer Patients

Penn Medicine Abramson Cancer Center

A. Garfall

349 views
59:57

Penn Medicine Updates on the Advances in BRCA-Related Breast Cancer …

Penn Medicine Abramson Cancer Center

S. Domchek

119 views
54:49

Updates and Management of Medullary Thyroid Cancer: Genetic Testing …

Penn Medicine Abramson Cancer Center

V. Livolsi, K. Nathanson, L. L. Sun, R. Kelz, S. Mandel

327 views
12:44

Advances in Adjuvant Therapy in NSCLC

Penn Medicine Abramson Cancer Center

C. Ciunci

891 views
08:56

47 y/o Male With Papillary Thyroid Cancer: How to Plan Surgery Strat…

Penn Medicine Abramson Cancer Center

S. Mandel, A. Chalian, S. Swisher-Mcclure

62 views
09:21

47 y/o Male With Papillary Thyroid Cancer: Radioiodine-131 Planning …

Penn Medicine Abramson Cancer Center

S. Mandel, D. Pryma

41 views
12:13

47 y/o Male With High-Risk Thyroid Cancer: How Does Surveillance Wor…

Penn Medicine Abramson Cancer Center

S. Mandel, M. Brose

34 views
19:24

47 y/o Male With High-Risk Thyroid Cancer: What Is the Right Timing …

Penn Medicine Abramson Cancer Center

S. Mandel, M. Brose, A. Chalian, D. Pryma, S. Swisher-Mcclure

35 views
07:27

Attributes of Low-Risk Thyroid Cancer: How to Predict Risk? AJCC TNM…

Penn Medicine Abramson Cancer Center

S. Mandel

27 views
07:21

Low-Risk Thyroid Cancer Surgery Approach: What Are the Factors Influ…

Penn Medicine Abramson Cancer Center

H. Wachtel

63 views
07:00

The Histopathology of Low-Risk Thyroid Cancer: How to Assess and Ide…

Penn Medicine Abramson Cancer Center

J. Jalaly

24 views
04:13

Radioiodine Therapy for Low-Risk Thyroid Cancer: When Should I-131 T…

Penn Medicine Abramson Cancer Center

B. Cooperberg

27 views
05:59

Management of Low-Risk Thyroid Cancer: Is There a Difference in Recu…

Penn Medicine Abramson Cancer Center

S. Mandel

42 views
20:30

53 y/o Female With Papillary Thyroid Cancer, Two Suspicious R Latera…

Penn Medicine Abramson Cancer Center

B. Cooperberg, S. Mandel, H. Wachtel

28 views
09:49

UPenn 2020 ASCO Updates on Early Local Therapy in mBC: Does ELT Impr…

Penn Medicine Abramson Cancer Center

A. Mateo

101 views
11:35

UPenn 2020 ASCO Updates on HER2+ Ductal Carcinoma in Site: Does Tras…

Penn Medicine Abramson Cancer Center

A. Mateo

80 views
07:01

UPenn 2020 ASCO Updates on mTNBC: Does the Addition of Pembro to Che…

Penn Medicine Abramson Cancer Center

J. Matro

92 views
09:01

UPenn 2020 ASCO Updates on PARPi in mTNBC: Does Veliparib Improve Ch…

Penn Medicine Abramson Cancer Center

J. Matro

29 views
05:41

UPenn 2020 ASCO Updates on Operable TNBC: What Is the Role of Adjuva…

Penn Medicine Abramson Cancer Center

J. Matro

119 views
08:58

UPenn 2020 ASCO Updates on ET in MBC: Is Fulvestrant + Alpelisib Eff…

Penn Medicine Abramson Cancer Center

P. Gor

138 views
09:35

UPenn 2020 ASCO Updates on Adjuvant ET in BC: In Pts Treated With an…

Penn Medicine Abramson Cancer Center

P. Gor

25 views
13:49

Updates on HER2+ MBC: HER2CLIMB OS/PFS Data on Tucatinib Combo in Pa…

Penn Medicine Abramson Cancer Center

H. Knollman

734 views
09:54

UPenn Updates on HER2+ EBC: CT De-Escalation Using F-PET, Adjuvant T…

Penn Medicine Abramson Cancer Center

T. D'Entremont

106 views
05:16

UPenn 2020 ASCO Updates on Stage 2/3 HER2+ BC: Do Anthracyclines Imp…

Penn Medicine Abramson Cancer Center

H. Knollman

173 views
09:42

UPenn 2020 ASCO Updates on Adjuvant ET in BC: Does the 70-Gene Signa…

Penn Medicine Abramson Cancer Center

P. Gor

21 views
33:02

UPenn 2020 ASCO Breast Cancer Q&A: Preoperative Anthracyclines for H…

Penn Medicine

H. Knollman, A. Mateo, J. Matro, T. D'Entremont

289 views
02:33

TumorGlow®: Illuminating Cancer Cells in the Operating Room

Penn Medicine Abramson Cancer Center

172 views
02:05

Advances in Precision Surgery with Penn Medicine’s TumorGlow™ Techno…

Penn Medicine Abramson Cancer Center

S. Singhal